WYJ-2
WYJ-2 is a selective agonist for toll-like receptor 2/1 (TLR2/1) with EC50 of 18.57 nM in human TLR2 and TLR1 transient-cotransfected HEK 293T cells. WYJ-2 induces pyroptosis and exhibits anticancer activity against non-small cell lung cancer (NSCLC).
For research use only. We do not sell to patients.
- CAS No.: 3029403-05-9
- Formula: C17H9F2N3O4
- Molecular Weight:357.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
TLR2 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | CC50 |
>100 μM
Compound: 2 WYJ-2
|
Cytotoxicity against human HEK293T cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
Cytotoxicity against human HEK293T cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
|
[PMID: 38498304] |
| RAW264.7 | CC50 |
>100 μM
Compound: 2 WYJ-2
|
Cytotoxicity against mouse RAW264.7 cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
Cytotoxicity against mouse RAW264.7 cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
|
[PMID: 38498304] |
| THP-1 | CC50 |
>100 μM
Compound: 2 WYJ-2
|
Cytotoxicity against human THP-1 cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
Cytotoxicity against human THP-1 cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
|
[PMID: 38498304] |
| THP-1 | CC50 |
>100 μM
Compound: 2 WYJ-2
|
Cytotoxicity against PMA differentiated human THP-1 cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
Cytotoxicity against PMA differentiated human THP-1 cells incubated for 24 hrs by CCK-8 reagent based colorimetric assay
|
[PMID: 38498304] |
WYJ-2 (0-10 μM) inhibits heterodimerization of TLR2 and TLR1 in THP-1 cells, stimulates the adaptor protein myeloid differentiation primary response protein 88 (MyD88) and then activates the NF-κB signaling pathway without significant cytotoxicity[1].
WYJ-2 (0-100 μM) inhibits proliferation in cancer cells A549, HeLa, HepG2 and MCF-7 with IC50 about 10 μM, induces cancer cell pyroptosis by activation of the NLRP3 inflammasome[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PAM-differentiated THP-1
-
Concentration:0-10 μM
-
Incubation Time:12 h
-
Result:Upregulated levels of MyD88, p-p65, TLR1 and TLR2.
Increased NLRP3.
-
Cell Line:PAM-differentiated THP-1
-
Concentration:0-10 μM
-
Incubation Time:12 h
-
Result:Induced translocation of p-p65 in nucleus.
WYJ-2 (10 mg/kg, i.p.) exhibits a pharmacokinetic profil with half-time of T1/2 of 3.67 h and a clearance Cmax of 497 ± 49 ng/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A549 xenograft BALB/c mice[1]
-
Dosage:5 mg/kg
-
Administration:i.p. every two days for 30 days
-
Result:Inhibited tumor growth with a TGI of 72.22% without significant loss of body weight.
Chemical Information
-
CAS No. 3029403-05-9
-
Molecular Weight 357.27
-
Formula C17H9F2N3O4
-
SMILES
FC1=CC=C(C=C1C2=NC(C3=CC4=CC(F)=CC=C4OC3)=NO2)[N+]([O-])=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
WYJ-2 Related Classifications
HY-158058 Related Classifications
Powered by Bioz